By evaluating the tumor levels of cGAS and STING with IHC in a large cohort retrospective study (n = 259), we found lower expression levels of cGAS and STING in patients with CRC (n = 259, Fig. 1A, B). This evidence concerns the gene CGAS and colorectal carcinoma.